Phase I Study of Temsirolimus and Cetuximab in Adults Patients With Advanced or Metastatic Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2018
Price : $35 *
At a glance
- Drugs Cetuximab (Primary) ; Temsirolimus (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Acronyms TORERO
- 27 Sep 2017 Status changed from recruiting to completed, based on the results published in the European Journal of Cancer.
- 01 Aug 2017 Results published in the European Journal of Cancer
- 02 Jun 2015 Interim results (n=39) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.